XERS

$0.00

(

0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Xeris Pharmaceuticals Inc

NASDAQ | XERS

7.71

USD

$0.00

(

0.00%

)

At Close (As of Nov 6, 2025)

$1.59B

Market Cap

-

P/E Ratio

-0.2

EPS

$10.08

52 Week High

$2.82

52 Week Low

HEALTHCARE

Sector

XERS Chart

Recent Chart
Price Action

XERS Technicals

Tags:

XERS Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $166M
Total Revenue $203M
Cost Of Revenue $37M
Costof Goods And Services Sold $37M
Operating Income -$34M
Selling General And Administrative $163M
Research And Development $26M
Operating Expenses $200M
Investment Income Net -
Net Interest Income -$28M
Interest Income $5.3M
Interest Expense $33M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $13M
Income Before Tax -$57M
Income Tax Expense -$2.3M
Interest And Debt Expense -
Net Income From Continuing Operations -$55M
Comprehensive Income Net Of Tax -
Ebit -$27M
Ebitda -$14M
Net Income -$55M

Revenue & Profitability

Earnings Performance

XERS Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $323M
Total Current Assets $168M
Cash And Cash Equivalents At Carrying Value $72M
Cash And Short Term Investments $72M
Inventory $48M
Current Net Receivables $40M
Total Non Current Assets $155M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets $99M
Intangible Assets Excluding Goodwill $99M
Goodwill $23M
Investments -
Long Term Investments -
Short Term Investments $0
Other Current Assets $7.5M
Other Non Current Assets -
Total Liabilities $353M
Total Current Liabilities $100M
Current Accounts Payable $2.3M
Deferred Revenue -
Current Debt -
Short Term Debt $21M
Total Non Current Liabilities $252M
Capital Lease Obligations $39M
Long Term Debt $217M
Current Long Term Debt $15M
Long Term Debt Noncurrent -
Short Long Term Debt Total $271M
Other Current Liabilities $77M
Other Non Current Liabilities $2M
Total Shareholder Equity -$30M
Treasury Stock -
Retained Earnings -$672M
Common Stock $15K
Common Stock Shares Outstanding $147M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$37M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $13M
Capital Expenditures $868K
Change In Receivables -
Change In Inventory -$8.8M
Profit Loss -
Cashflow From Investment $4.9M
Cashflow From Financing $36M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -$3.7M
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$55M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $166M
Total Revenue $203M
Cost Of Revenue $37M
Costof Goods And Services Sold $37M
Operating Income -$34M
Selling General And Administrative $163M
Research And Development $26M
Operating Expenses $200M
Investment Income Net -
Net Interest Income -$28M
Interest Income $5.3M
Interest Expense $33M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $13M
Income Before Tax -$57M
Income Tax Expense -$2.3M
Interest And Debt Expense -
Net Income From Continuing Operations -$55M
Comprehensive Income Net Of Tax -
Ebit -$27M
Ebitda -$14M
Net Income -$55M

XERS News

XERS Profile

Xeris Pharmaceuticals Inc Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Xeris Pharmaceuticals, Inc. is a pioneering specialty pharmaceutical company headquartered in Chicago, Illinois, dedicated to the development and commercialization of ready-to-use injectable and infusible drug formulations. Utilizing its proprietary formulation technology, Xeris enhances patient care by improving the delivery and efficacy of therapeutics across critical therapeutic areas, including diabetes and oncology. The company is strategically positioned to address unmet medical needs, making it a compelling investment opportunity in the dynamic healthcare sector as it looks to capitalize on growing market demands.

WORX
+33.21%
$0.38
YGMZ
+44.57%
$0.18
BIYA
+73.32%
$0.47
NVDA
-3.65%
$188.08
ASST
-0.68%
$1.45
EZGO
+37.90%
$0.20
BYND
-6.29%
$1.19
CHR
-14.86%
$0.06
SNAP
+9.72%
$8.01
MTC
+25.33%
$2.77
PFE
+0.97%
$24.85
TSLA
-3.49%
$445.91
AZI
+12.92%
$0.09
VHAI
0.00%
$0.00
RIVN
-1.29%
$15.22
PLUG
-4.92%
$2.50
SOFI
-9.67%
$27.16
DNN
-4.11%
$2.56
IOVA
+27.62%
$2.31
F
+0.07%
$13.12
ONDS
-12.50%
$5.25
PLTR
-6.83%
$175.05
WTO
-6.25%
$0.04
YDKG
0.00%
$0.05
INTC
-2.97%
$37.24
STGW
+16.83%
$5.62
T
+0.73%
$24.74
NIO
-1.78%
$7.16
BITF
-9.11%
$3.69
AXDX
-61.36%
$0.03
AAL
-2.01%
$13.15
AMD
-7.26%
$237.70
FTEL
-31.98%
$1.51
KVUE
+1.41%
$16.46
ACHR
-7.21%
$8.88
BURU
-6.81%
$0.27
BAC
+1.60%
$53.29
CIFR
-12.14%
$21.71
GRAB
-0.17%
$5.63
AAPL
-0.13%
$269.77
ADAP
-15.14%
$0.05
LYFT
+5.82%
$21.25
BTG
-5.70%
$3.80
HOOD
-10.80%
$127.08
IREN
-12.36%
$66.95
WBD
-1.49%
$22.42
IONZ
-7.99%
$3.80
ETHD
+8.25%
$4.84
RGTI
-7.85%
$34.36
AMZN
-2.86%
$243.04
NUAI
+6.52%
$6.04
NEHC
+6.52%
$6.04
NVO
-4.02%
$46.51
HIMS
-5.05%
$41.52
EPWK
+1.42%
$0.07
BTBT
-7.62%
$3.03
AMCR
+1.85%
$8.22
SOUN
-9.47%
$14.23
QBTS
-8.47%
$28.39
XPEV
+9.63%
$23.89
GPUS
-4.97%
$0.37
RMBL
+60.50%
$3.21
DVLT
-15.00%
$1.36
JOBY
-4.53%
$14.32
CELH
-24.79%
$45.06
MARA
-6.83%
$15.96
BMNR
-9.77%
$37.36
ADD
-25.47%
$0.05
RIG
0.00%
$3.90
RXRX
-6.85%
$4.62
CAN
-12.40%
$1.12
HL
+11.89%
$13.55
TLRY
-5.46%
$1.21
EOSE
+2.89%
$15.29
GOOGL
+0.15%
$284.75
IONQ
+3.64%
$57.43
SRM
+53.27%
$10.30
NOK
+0.87%
$6.91
DKNG
+0.21%
$27.98
WULF
-7.03%
$14.28
VALE
-0.64%
$12.23
RUBI
-26.47%
$0.22
BBD
-0.56%
$3.51
PINS
+2.05%
$26.28
SMCI
-4.03%
$40.33
PLTZ
+13.94%
$7.11
CMG
-4.41%
$30.56
MU
+0.34%
$238.33
ACVA
-37.54%
$5.09
VZ
+0.32%
$39.82
OSCR
-2.75%
$16.55
PLTD
+6.98%
$6.89
CCC
-2.80%
$7.62
CCCS
-2.80%
$7.62
NGD
+1.76%
$6.92
KHC
-1.73%
$23.72
KMX
-24.33%
$30.88
ABEV
-0.82%
$2.40
WLGS
-5.57%
$0.04
MRVL
+0.46%
$93.33
WORX
+33.21%
$0.38
YGMZ
+44.57%
$0.18
BIYA
+73.32%
$0.47
NVDA
-3.65%
$188.08
ASST
-0.68%
$1.45
EZGO
+37.90%
$0.20
BYND
-6.29%
$1.19
CHR
-14.86%
$0.06
SNAP
+9.72%
$8.01
MTC
+25.33%
$2.77
PFE
+0.97%
$24.85
TSLA
-3.49%
$445.91
AZI
+12.92%
$0.09
VHAI
0.00%
$0.00
RIVN
-1.29%
$15.22
PLUG
-4.92%
$2.50
SOFI
-9.67%
$27.16
DNN
-4.11%
$2.56
IOVA
+27.62%
$2.31
F
+0.07%
$13.12
ONDS
-12.50%
$5.25
PLTR
-6.83%
$175.05
WTO
-6.25%
$0.04
YDKG
0.00%
$0.05
INTC
-2.97%
$37.24
STGW
+16.83%
$5.62
T
+0.73%
$24.74
NIO
-1.78%
$7.16
BITF
-9.11%
$3.69
AXDX
-61.36%
$0.03
AAL
-2.01%
$13.15
AMD
-7.26%
$237.70
FTEL
-31.98%
$1.51
KVUE
+1.41%
$16.46
ACHR
-7.21%
$8.88
BURU
-6.81%
$0.27
BAC
+1.60%
$53.29
CIFR
-12.14%
$21.71
GRAB
-0.17%
$5.63
AAPL
-0.13%
$269.77
ADAP
-15.14%
$0.05
LYFT
+5.82%
$21.25
BTG
-5.70%
$3.80
HOOD
-10.80%
$127.08
IREN
-12.36%
$66.95
WBD
-1.49%
$22.42
IONZ
-7.99%
$3.80
ETHD
+8.25%
$4.84
RGTI
-7.85%
$34.36
AMZN
-2.86%
$243.04
NUAI
+6.52%
$6.04
NEHC
+6.52%
$6.04
NVO
-4.02%
$46.51
HIMS
-5.05%
$41.52
EPWK
+1.42%
$0.07
BTBT
-7.62%
$3.03
AMCR
+1.85%
$8.22
SOUN
-9.47%
$14.23
QBTS
-8.47%
$28.39
XPEV
+9.63%
$23.89
GPUS
-4.97%
$0.37
RMBL
+60.50%
$3.21
DVLT
-15.00%
$1.36
JOBY
-4.53%
$14.32
CELH
-24.79%
$45.06
MARA
-6.83%
$15.96
BMNR
-9.77%
$37.36
ADD
-25.47%
$0.05
RIG
0.00%
$3.90
RXRX
-6.85%
$4.62
CAN
-12.40%
$1.12
HL
+11.89%
$13.55
TLRY
-5.46%
$1.21
EOSE
+2.89%
$15.29
GOOGL
+0.15%
$284.75
IONQ
+3.64%
$57.43
SRM
+53.27%
$10.30
NOK
+0.87%
$6.91
DKNG
+0.21%
$27.98
WULF
-7.03%
$14.28
VALE
-0.64%
$12.23
RUBI
-26.47%
$0.22
BBD
-0.56%
$3.51
PINS
+2.05%
$26.28
SMCI
-4.03%
$40.33
PLTZ
+13.94%
$7.11
CMG
-4.41%
$30.56
MU
+0.34%
$238.33
ACVA
-37.54%
$5.09
VZ
+0.32%
$39.82
OSCR
-2.75%
$16.55
PLTD
+6.98%
$6.89
CCC
-2.80%
$7.62
CCCS
-2.80%
$7.62
NGD
+1.76%
$6.92
KHC
-1.73%
$23.72
KMX
-24.33%
$30.88
ABEV
-0.82%
$2.40
WLGS
-5.57%
$0.04
MRVL
+0.46%
$93.33
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.